Cancer-specific mortality of high-risk prostate cancer after carbon-ion radiotherapy plus long-term androgen deprivation therapy.

about

Cancer-specific mortality of high-risk prostate cancer after carbon-ion radiotherapy plus long-term androgen deprivation therapy.

Item

http://www.wikidata.org/entity/Q47100168

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Cancer-specific mortality of h ...... androgen deprivation therapy.

@en

Cancer-specific mortality of h ...... androgen deprivation therapy.

@nl

type

Item

label

Cancer-specific mortality of h ...... androgen deprivation therapy.

@en

Cancer-specific mortality of h ...... androgen deprivation therapy.

@nl

prefLabel

Cancer-specific mortality of h ...... androgen deprivation therapy.

@en

Cancer-specific mortality of h ...... androgen deprivation therapy.

@nl

P1476

Cancer-specific mortality of h ...... m androgen deprivation therapy

@en

P2093

Daniel K Ebner

http://www.w3.org/2001/XMLSchema#string

Gen Kobashi

http://www.w3.org/2001/XMLSchema#string

Hirohiko Tsujii

http://www.w3.org/2001/XMLSchema#string

Hirokazu Makishima

http://www.w3.org/2001/XMLSchema#string

Hiroshi Tsuji

http://www.w3.org/2001/XMLSchema#string

Hiroyoshi Suzuki

http://www.w3.org/2001/XMLSchema#string

Hitoshi Ishikawa

http://www.w3.org/2001/XMLSchema#string

Jun Shimazaki

http://www.w3.org/2001/XMLSchema#string

Koichiro Akakura

http://www.w3.org/2001/XMLSchema#string

Tadashi Kamada

http://www.w3.org/2001/XMLSchema#string

P2860

Significant impact of biochemical recurrence on overall mortality in patients with high-risk prostate cancer after carbon-ion radiotherapy combined with androgen deprivation therapy.

What are the outcomes of radical prostatectomy for high-risk prostate cancer?

National Comprehensive Cancer Network guidelines for the management of prostate cancer.

Tri-Modality therapy with I-125 brachytherapy, external beam radiation therapy, and short- or long-term hormone therapy for high-risk localized prostate cancer (TRIP): study protocol for a phase III, multicenter, randomized, controlled trial.

Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference.

Intensity-modulated radiotherapy versus radical prostatectomy in patients with localized prostate cancer: long-term follow-up.

Long-term survival after radical prostatectomy versus external-beam radiotherapy for patients with high-risk prostate cancer

The radiobiology of prostate cancer including new aspects of fractionated radiotherapy.

The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.

Treatment outcome of high-dose image-guided intensity-modulated radiotherapy using intra-prostate fiducial markers for localized prostate cancer at a single institute in Japan.

P304

2422-2429

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CAS.13402

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

108

http://www.w3.org/2001/XMLSchema#string

P50

Goro Kasuya

P577

2017-11-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28921785

http://www.w3.org/2001/XMLSchema#string

P932

5715357

http://www.w3.org/2001/XMLSchema#string